Finding out you’re sick is hard enough. Finding out you have a disease shared by less than 1% of the population with no established treatment is something else entirely. Rare disease breaks the ...
Pelareorep-based treatment regimen recently granted Fast Track Designation in 2L KRAS-mutant MSS metastatic colorectal cancer, confirming its potential in this large indication SAN DIEGO, March 02, ...
Last year was characterized by fewer but larger venture capital financings for biotech, with 2025’s top 10 private rounds bringing in nearly $4 billion collectively. As venture markets rebounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results